LeddarTech today announced the closing of its latest round of venture capital financing for $2.5 million. LeddarTech is the owner of the patented LeddarTM LED-based detection technology, a 3D detection solution that combines LED lighting and innovative signal processing into an accurate and robust detection solution. iSource, Accès Capital and Desjardins-Innovatech also participated in the financing led by GO Capital LP and BDC Venture Capital.

Atrium Innovations Inc., an international manufacturer and distributor of science-based dietary supplements, is planning an acquisition in the $100-million range after completing its current vertical integration program, CEO Pierre Fitzgibbon said Tuesday.

Atrium Innovations announces that it has extended its research partnership with the Institute of Nutrition and Functional Foods ("INAF"). In June 2011, Atrium launched a comprehensive applied clinical research program in collaboration with INAF at Université Laval in Quebec City. The original program was funded through the end of 2013.

Medicago announced that it has successfully produced a new VLP vaccine candidate for the H7N9 virus that is responsible for the current influenza outbreak in China. "To our knowledge, Medicago is the first to produce a VLP vaccine candidate against this potential pandemic strain demonstrating our ability to be a first responder in a pandemic scenario," said Andy Sheldon, President and CEO of Medicago.

AmorChem and InflammatoRx are proud to announce the launch of a research collaboration on inflammatory and auto-immune diseases. The collaboration targets S100A9, a protein playing a key role in inflammation as demonstrated by Dr. Philippe Tessier (Professor, Department of Microbiology, Infectiology and Immunology at the Faculty of Medicine of Université Laval). InflammatoRx, a biotechnology company, was started up in 2009 around the work of Dr. Tessier.

Baldor, a member of the ABB Group, is pleased to announce that Investissement Québec has agreed to support investments in the Baldor St-Claire facility. The investment is intended to increase production capacity and modernise its equipment in preparation for moving a production line from Mexico to Quebec.

CO2 Solutions announces that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application entitled Methods And Formulations Using Carbonic Anhydrase And Reaction Compound Combinations.

Structal-Bridges, a division of Canam Group Inc. (TSX: CAM), has secured two large contracts totaling close to $60M for the fabrication of the steel structures that will replace the Sir Ambrose Shea Lift Bridge in Placentia, located in the province of Newfoundland and Labrador, Canada, and the John Greenleaf Whittier Memorial Bridge, which overlooks the Merrimack River between Newburyport and Amesbury in the state of Massachusetts.

CO2 Solutions is featured in the May/June 2013 issue of the subscription-based Carbon Capture Journal. The Company is highlighted as an example of Canada’s leadership in the development of proprietary carbon capture technologies, particularly as they relate to the Alberta Oil Sands industry. Articles featuring CO2 Solutions can be found on pages 5, 13 and 26. CO2 Solutions is developing carbon capture technology for use in oil sands production, including in-situ methods such as Steam Assisted Gravity Drainage, and bitumen upgrading.

CQDM is joining the Massachusetts Life Sciences Center (MLSC) in a new initiative to create an International Collaborative Industry Program (ICIP). This initiative is a concrete action to promote and facilitate the establishment of partnerships between Massachusetts and Quebec-based life sciences companies for research and development of new products and processes intended for commercialization.

Medicago and The Infectious Disease Research Institute (IDRI), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, reported positive interim results from a Phase I clinical trial for an H5N1 Avian Influenza VLP vaccine candidate ("H5N1 vaccine").

Lucas Meyer Cosmetics, a wholly owned subsidiary of Unipex Group, and leading company in the field of innovative active and functional ingredients for the cosmetics industry, announced that it has acquired Southern Cross Botanicals, the leading supplier of Australian botanical ingredients. This acquisition will expand the Lucas Meyer Cosmetics product line and is perfectly in line with its corporate vision, which focuses on innovation and client satisfaction.

La Capitale Financial Group has received the 2013 Best Real Estate Project award for its head office expansion. La Capitale received this award during the Montreal Real Estate Forum, in the Real Estate Evening of the Urban Development Institute of Quebec (UDI Quebec) held on Wednesday, April 3.

Nemaska Lithium announced that they have begun the execution of their lithium hydroxide marketing strategy beginning in Asia where numerous battery cathode manufacturers are located. The Company's CEO, Guy Bourassa, and Technical Manager, Jean Francois Magnan, are in Asia this week to initiate discussions with key customers for supply of lithium hydroxide products. The two will begin the trip in Taiwan, then onto to Hong Kong and Mainland China. In addition, Mr. Bourassa has been invited as a featured speaker at the 5th World Cobalt and Lithium Forum held in Chengdu, China.

ISO (the International Organization for Standardization) 9001: 2008 specifies the requirements for a quality management system and the processes for continuous improvement and assurance of conformity to customer, regulatory and statutory applicable provisions. By this certification the company demonstrates its capacity to consistently provide products that meet customer requirements. This certification is in direct connection with the sustained implementation, in the recent years, of a culture of continuous improvement where each member of the company contributes daily to improve the customer experience while creating value for shareholders.

Frima Studio is diving headfirst into the children’s animation industry, announcing a new co-production agreement on the eve of MipTV in Cannes, France. In the wake of their recent agreement to co-produce the Squids series with Moonscoop, Frima continues expanding their animation footprint with an ambitious new project, Phoenix Park.

Aeterna Zentaris announces the signing of a co-development and profit sharing agreement with Ergomed Clinical Research Ltd. for AEZS-108 in endometrial cancer. Ergomed was selected as the contract clinical development organization to conduct the multicenter, multinational, randomized Phase 3 trial with AEZS-108 in endometrial cancer.